Where to Buy NAD+ in the Philippines

No Philippine pharmacy counter sells injectable NAD+. What exists instead are two structurally different purchases that people tend to compare on session price rather than on what they actually deliver.

The Philippines is a good place to buy either. A drip session that costs USD 500 to 1,000 at a hospital in the US or Europe costs USD 150 to 350 at Makati Med or Manila Doctors for the same pharmaceutical-grade NAD+ on the same slow-drip protocol. The vial side is similarly favourable because regional suppliers are close, which matters more here than price, for reasons covered below.

This is where the two routes stop being comparable. A clinic drip delivers roughly 250 to 1,000mg per session. A home subcutaneous loading dose is 100 to 200mg, three to five times weekly for two to four weeks, dropping to 50 to 100mg one to three times weekly on maintenance.

Run a full loading block through each. Five to ten clinic sessions, which is the standard loading phase, is USD 750 to 3,500 at hospital rates before you have started monthly maintenance. The same total material through vials, at USD 50 to 80 a vial from a verified regional supplier, is a fraction of that. I am not going to publish a precise multiplier because the compound files do not state the milligram content behind that USD 50 to 80 figure, and neither should anyone else. Work it out from your own written quote: ask for the vial size in milligrams, then divide.

Three things separate a workable NAD+ supplier from an unworkable one in this market, and price is not among them.

Proximity. A verified Asian supplier beats a US peptide company on this compound not only on the USD 50 to 80 versus USD 150 to 200 spread, but on transit hours. Every hour in a warm bag is a real cost for NAD+ specifically.

Documentation. The same COA discipline applies here as everywhere else on this site: HPLC purity, a batch number matching the vial in your hand, and a COA dated to that batch rather than a recycled PDF. The method is on the COA reference page. Vetted supplier and clinic notes are kept on the supply page.

Packaging you can inspect. Ask what the cold pack configuration is and what happens if the parcel arrives warm. A supplier who has never been asked that question will tell you so by how they answer it.

NAD+ degrades quickly at room temperature. That sentence does more work in a Philippine buying decision than anywhere else, because it means the cheapest vial and the intact vial are frequently not the same vial, and you cannot tell them apart by looking.

Cold-chain shipping is required rather than recommended. After reconstitution the vial must be refrigerated and used within 2 to 3 weeks, which is a shorter window than the 4 to 6 weeks many other peptides tolerate. The two domestic failure modes are the same ones that catch every compound here: the warm ride home from the courier handoff, and an overnight brownout on a condo fridge. Neither leaves evidence.

The practical consequence for buying is that stock already sitting inside the Philippines has an advantage on this compound that it does not have on, say, lyophilized BPC-157. There is no international leg to survive and no clearance window to sit through. Bulk-buying to chase a per-vial discount is the wrong instinct here. Buy the volume you will reconstitute inside a month.

Two handling notes that change what you buy alongside the vial. First, subcutaneous NAD+ stings at the injection site more than other peptides because of the molecule size. Diluting properly and injecting slowly helps, which means buying more bacteriostatic water than you would for a micro-dosed peptide and not economising on syringe gauge.

Second, the short post-reconstitution window means your vial size should match your protocol, not your budget. A large vial you cannot finish in 2 to 3 weeks is money in the bin. Reconstitution mechanics are in the reconstituted peptides note and the water question is covered in bacteriostatic versus sterile water.

Buy the drip if you want a small number of sessions, want supervision, are nervous about infusion side effects, or simply do not want a peptide operation running out of your fridge. It is the right call for a first exposure and for anyone who would not reliably hold cold-chain.

Buy the vial if you are already running peptide protocols, hold refrigeration discipline through a Philippine summer, and are looking at a loading block plus ongoing maintenance where the per-milligram gap compounds into real money. This is also the route for people stacking NAD+ with MOTS-c and Epitalon, since you are already handling vials.

Neither route is appropriate during pregnancy or breastfeeding, with active cancer without an oncologist in the conversation, or for high-dose IV with a history of severe cardiovascular disease. The full contraindication list is on the compound page.